Studies related to Interleukin 1-alpha and Astaxanthin

Protective Effects Of Astaxanthin On Skin Deterioration

Effect Both
Values Figure 6
Trial Design Randomized trial
Trial Length 1-6 months
Number of Subjects 65
Sex Female
Age Range 30-44, 45-64
Notes for this study:
In a randomized, double-blind, placebo-controlled trial, 65 participants were allocated to take 0, 6, or 12 mg of astaxanthin daily for 16 weeks.

The area of wrinkles didn't differ at the end of 16 weeks, though the depth increased slightly less in the astaxanthin groups than in the placebo groups, with no difference between them. The low dose group saw a somewhat greater improvement in elasticity than the other groups, which was statistically significant, and the low-dose group saw the greatest increase in IL-1alpha, while the high dose group saw the least.

There weren't statistically significant differences in the change in a wide variety of safety markers, except for a small change in sodium and calcium levels for the low and high dose groups, respectively.